Bio-Rad Laboratories Ownership | Who Owns Bio-Rad Laboratories?


OverviewForecastRevenueFinancialsChartTranscripts

Bio-Rad Laboratories Ownership Summary


Bio-Rad Laboratories is owned by 70.41% institutional investors, 16.19% insiders, and 13.39% retail investors. Vanguard group is the largest institutional shareholder, holding 6.87% of BIO shares. First Eagle Global A is the top mutual fund, with 6.94% of its assets in Bio-Rad Laboratories shares.

BIO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBio-Rad Laboratories70.41%16.19%13.39%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryMedical Device Stocks52.08%10.61%37.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group1.92M6.87%$630.68M
Blackrock funding, inc. /de1.76M6.47%$425.36M
Blackrock1.55M5.44%$423.48M
Veritas asset management llp863.14K3.17%$208.29M
Ariel investments818.62K3.01%$197.55M
Dimensional fund advisors lp746.12K2.67%$245.11M
First eagle investment management713.50K2.55%$234.39M
State street690.16K2.47%$226.71M
Earnest partners618.05K2.21%$203.04M
Bank of america corp /de/441.88K1.55%$120.68M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Qvidtvm management126.08K30.47%$30.43M
Soditic asset management llp31.73K10.04%$8.66M
Jne partners llp92.10K8.94%$22.23M
Tikvah management111.08K8.63%$26.81M
Hound partners181.94K5.93%$43.90M
Southeastern asset management inc/tn/315.29K3.84%$76.08M
Rk asset management14.50K3.37%$3.50M
Scopia capital management lp94.74K2.79%$22.86M
Ariel investments818.62K2.24%$197.55M
Veritas asset management llp863.14K2.08%$208.29M

Top Buyers

HolderShares% AssetsChange
Bank of america corp /de/441.88K0.01%412.56K
Norges bank126.77K0.01%126.77K
Ilex capital partners (uk) llp120.89K0.97%114.49K
Scopia capital management lp94.74K2.79%94.74K
Ariel investments818.62K2.24%93.96K

Top Sellers

HolderShares% AssetsChange
Wealthfront advisers---1.04M
Van eck associates40.25K0.01%-556.48K
Ninety one uk---387.31K
Blackrock funding, inc. /de1.76M0.01%-259.06K
Millennium management379.08K0.06%-204.72K

New Positions

HolderShares% AssetsChangeValue
Norges bank126.77K0.01%126.77K$41.64M
Scopia capital management lp94.74K2.79%94.74K$22.86M
Jne partners llp92.10K8.94%92.10K$22.23M
T. rowe price investment management48.20K0.01%48.20K$11.63M
Arnhold34.78K0.77%34.78K$8.39M

Sold Out

HolderChange
Carolinas wealth consulting-1.00
Mcf advisors-1.00
Bruce g. allen investments-1.00
Claris advisors, llc / mo /-1.00
True wealth design-1.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025378-12.50%19,170,530-0.76%701.47%168-17.24%161-1.83%
Mar 31, 2025423-6.83%19,297,166-2.78%691.37%198-12.39%16112.59%
Dec 31, 20244442.07%19,823,0275.33%701.56%21710.71%141-14.55%
Sep 30, 2024431-2.05%18,795,333-5.21%671.39%194-1.02%162-7.95%
Jun 30, 2024429-9.11%19,813,30010.21%691.75%189-14.09%1732.98%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
First Eagle Global A1.88M6.94%-
UBS: Global Equity695.49K2.48%-
iShares Core S&P Mid-Cap ETF606.18K2.24%-1.10K
Vanguard Total Stock Mkt Idx Inv599.02K2.21%-16.80K
Vanguard US Total Market Shares ETF613.97K2.19%-14.43K
VanEck Morningstar Wide Moat537.18K1.92%-635.23K
Vanguard Institutional 500 Index Trust533.54K1.91%4.24K
VanEck Morningstar Wide Moat ETF495.12K1.82%-1.41K
Vanguard Small Cap Index456.98K1.69%-3.08K
Ariel Fund Investor347.00K1.28%46.52K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 14, 2025Crowley Michael EVP, GBL Commercial OperationsSell$741.18K
Sep 06, 2024Last Andrew J. EVP, Chief Operating OfficerSell$989.82K
Sep 04, 2024BARRY JAMES EVP, President, LSGSell$205.90K
Jun 13, 2024Crowley Michael EVP, GBL Commercial OperationsSell$104.02K
May 03, 2023SCHWARTZ STEVEN D-Sell$148.44K

Insider Transactions Trends


DateBuySell
2023 Q4-2
2023 Q3-4
2023 Q2-3
2023 Q1-2
2022 Q4-3

BIO Ownership FAQ


Who Owns Bio-Rad Laboratories?

Bio-Rad Laboratories shareholders are primarily institutional investors at 70.41%, followed by 16.19% insiders and 13.40% retail investors. The average institutional ownership in Bio-Rad Laboratories's industry, Medical Device Stocks, is 52.08%, which Bio-Rad Laboratories exceeds.

Who owns the most shares of Bio-Rad Laboratories?

Bio-Rad Laboratories’s largest shareholders are Vanguard group (1.92M shares, 6.87%), Blackrock funding, inc. /de (1.76M shares, 6.47%), and Blackrock (1.55M shares, 5.44%). Together, they hold 18.78% of Bio-Rad Laboratories’s total shares outstanding.

Does Blackrock own Bio-Rad Laboratories?

Yes, BlackRock owns 5.44% of Bio-Rad Laboratories, totaling 1.55M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 423.48M$. In the last quarter, BlackRock increased its holdings by 70.66K shares, a 4.78% change.

Who is Bio-Rad Laboratories’s biggest shareholder by percentage of total assets invested?

Qvidtvm management is Bio-Rad Laboratories’s biggest shareholder by percentage of total assets invested, with 30.47% of its assets in 126.08K Bio-Rad Laboratories shares, valued at 30.43M$.

Who is the top mutual fund holder of Bio-Rad Laboratories shares?

First Eagle Global A is the top mutual fund holder of Bio-Rad Laboratories shares, with 6.94% of its total shares outstanding invested in 1.88M Bio-Rad Laboratories shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools